Immudex Usa, LLC
Fairfax, VA Doing business as Immudex USA LLC Immudex USA
- UEI
- TBNLHW1MFEJ1
- CAGE
- 63GQ8
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 10615 Judicial Dr #402, Fairfax, VA 22030, USA
- Website
- immudex.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Dcode dextramer. 30 days ARO. | Office of Logisitics and Acquisition Operations | $52,486 | |
| NCI - custom MHC class II HLA-DP xynapse and dextramer reagents for liver cancer neoantigen validation | Office of Logisitics and Acquisition Operations | $24,964 | |
| Dextramers needed for human tarp studies | National Cancer Institute | $11,109 | |
| Custom TCR reagents for study of CD8 t-cell receptor function in HIV-1 and covid-19 | National Institute of Allergy and Infectious Diseases | $47,575 | |
| MHC dextramer H2 DB abuabulabultvflpe, 500 test, #JA3566 quote #240817 | National Institute of Allergy and Infectious Diseases | $4,771 |
About Immudex Usa, LLC
Immudex USA, LLC is a foreign-owned, for-profit corporate entity registered in SAM.gov since August 2010, with current registration valid through October 30, 2025. The company specializes in providing advanced biological research reagents, particularly custom-designed molecular tools for scientific research, with a primary focus on immunological and infectious disease studies. Located in Fairfax, Virginia, Immudex USA appears to be a niche scientific supplier that develops specialized reagents for complex medical research applications.
In its federal contract awards, Immudex USA has demonstrated expertise in producing highly specialized research reagents for government agencies, specifically within the National Institutes of Health (NIH). The company has been awarded contracts by the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, delivering custom products such as dextramers for human TARP studies and T-cell receptor reagents for HIV-1 and COVID-19 research. These contracts, ranging from $11,109 to $47,575.30, indicate the company's capability to design and produce intricate molecular research tools. The contracts have been firm fixed-price purchases and call orders, with no specific set-aside designations, suggesting open competition for these awards.
Immudex USA has secured a significant Blanket Purchase Agreement (BPA) with the Department of Health and Human Services' Office of Logistics and Acquisition Operations, with a substantial ceiling value of $10,000,000.00. This single-award IDV, effective from October 31, 2024 to October 31, 2025, is specifically focused on the procurement of blood and blood products. The BPA represents a strategic contract vehicle that provides the agency with a streamlined mechanism for acquiring essential biological materials. This IDV demonstrates the company's expanding capabilities and potential for larger-scale federal contract work beyond its initial specialized reagent production.
Quick answers
What is Immudex Usa, LLC's UEI?
Immudex Usa, LLC's Unique Entity ID (UEI) in SAM.gov is TBNLHW1MFEJ1.
What is Immudex Usa, LLC's CAGE code?
Immudex Usa, LLC's CAGE code is 63GQ8.
What is Immudex Usa, LLC's primary NAICS code?
Immudex Usa, LLC's primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Immudex Usa, LLC located?
Immudex Usa, LLC's physical address in SAM.gov is 10615 Judicial Dr #402, Fairfax, VA 22030, USA.
Is Immudex Usa, LLC registered in SAM.gov?
Yes. Immudex Usa, LLC's SAM.gov registration is active through July 28, 2027.
What is Immudex Usa, LLC's most recent federal award?
Immudex Usa, LLC's most recent federal contract award is Dcode dextramer. 30 days ARO (75N98026P01802), from Office of Logisitics and Acquisition Operations, on September 23, 2026.
On GovTribe
See Immudex Usa, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors